NCT01348568

Brief Summary

Healthy individuals with type 2 diabetes will receive intensive counseling on food selection to improve glucose control using either high cereal fiber dietary strategies or low glycemic index foods especially canola oil containing bread. The treatments will last 3 months with bloods taken for HbA1c, glucose and blood lipids. If the study shows a benefit for either or both diets, then use of high fiber, and/or low glycemic index foods with canola oil, may provide another potential way to improve glucose control and lower cholesterol levels in non-insulin dependent diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
141

participants targeted

Target at P50-P75 for phase_2 type-2-diabetes

Timeline
Completed

Started Mar 2011

Longer than P75 for phase_2 type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 5, 2011

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

December 8, 2015

Status Verified

December 1, 2015

Enrollment Period

2.1 years

First QC Date

May 4, 2011

Last Update Submit

December 7, 2015

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in HbA1c

    from prestudy and week 0, to end of treatment weeks 8, 10, and 12

  • change in serum lipids

    from prestudy and week 0, to end of treatment weeks 8, 10, and 12

Secondary Outcomes (6)

  • fasting glucose

    from prestudy and week 0, to end of treatment weeks 8, 10, and 12

  • change in weight, waist, and hip circumference

    weeks 0 to 12

  • change in blood pressure

    from prestudy and week 0, to end of treatment weeks 8, 10, and 12

  • creatinine, urea, and c-peptides in 24 hour urine collection

    0, 12 weeks

  • endothelial function

    week 0, 12

  • +1 more secondary outcomes

Study Arms (2)

Low glycemic index diet with canola oil bread

EXPERIMENTAL

Subjects will be given whole wheat bread which includes canola oil, and advised to follow a diabetic diet using low glycemic index foods.

Dietary Supplement: low glycemic index diet with canola oil bread

high fiber diet

ACTIVE COMPARATOR

Subjects will be given whole wheat bread, and advised to follow a healthy high fiber diabetic diet.

Dietary Supplement: High fiber diet

Interventions

Low glycemic index diet with canola oil bread
High fiber dietDIETARY_SUPPLEMENT
high fiber diet

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women with type 2 diabetes who
  • are treated with oral hypoglycemic agents at a stable dose for at least 8 weeks
  • have a HbA1c in the range of 6.5 to 8.5% at the initial screening visit and at the prestudy visit (visit just prior to randomization)
  • have diabetes diagnosed \>6 months
  • have maintained stable weight for 2 months (within 3%)
  • have a valid OHIP card and a family physician
  • if prescribed lipid medication, have taken a stable dose for at least 2 weeks
  • if prescribed blood pressure medication, have taken a stable dose for at least 1 week
  • can keep written food records, with the use of a digital scale

You may not qualify if:

  • take insulin
  • take steroids
  • have GI disease (gastroparesis, celiac disease, ulcerative colitis, Crohn's Disease, IBS)
  • have had a major cardiovascular event (stroke or myocardial infarction) in the past 6 months
  • take warfarin (Coumadin)
  • have had major surgery in the past 6 months
  • have a major debilitating disorder
  • have clinically significant liver disease (AST or ALT \> 130 U/L), excluding NAFL or NASH
  • have hepatitis B or C
  • have renal failure (high creatinine \> 150 mmol/L)
  • have serum triglycerides ≥ 6.0 mmol/L
  • have a history of cancer, except non-melanoma skin cancer (basal cell, squamous cell)
  • have food allergies to canola oil, study food components
  • have elevated blood pressure (\> 145/90) unless approved by General Practitioner (GP)
  • have acute or chronic infections (bacterial or viral)
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Michael's Hospital

Toronto, Ontario, M5C2T2, Canada

Location

Related Publications (1)

  • Jenkins DJ, Kendall CW, Vuksan V, Faulkner D, Augustin LS, Mitchell S, Ireland C, Srichaikul K, Mirrahimi A, Chiavaroli L, Blanco Mejia S, Nishi S, Sahye-Pudaruth S, Patel D, Bashyam B, Vidgen E, de Souza RJ, Sievenpiper JL, Coveney J, Josse RG, Leiter LA. Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial. Diabetes Care. 2014 Jul;37(7):1806-14. doi: 10.2337/dc13-2990. Epub 2014 Jun 14.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • David J A Jenkins, MD, DSc

    Dept of Nutritional Science, University of Toronto, Toronto, ON, Canada

    PRINCIPAL INVESTIGATOR
  • Cyril W C Kendall, PhD

    Dept of Nutritional Science, University of Toronto, Toronto, Canada

    PRINCIPAL INVESTIGATOR
  • Robert Josse, MD

    Dept of Medicine, Div of Endocrinology and Metabolism, St. Michael's, Toronto, ON, Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

May 4, 2011

First Posted

May 5, 2011

Study Start

March 1, 2011

Primary Completion

April 1, 2013

Study Completion

March 1, 2015

Last Updated

December 8, 2015

Record last verified: 2015-12

Locations